Skip to main navigation Skip to search Skip to main content

U.S. Clinical Trial: Ju Hyun Shim Listed a New Clinical Trial to Study Regorafenib After Treatment Failure of First Line Immune Checkpoint Inhibitor Treatment in Advanced Hepatocellular Carcinoma Patients (RECOMEND)

Press/Media

Period2026.04.7

Media coverage

1

Media coverage

  • TitleU.S. Clinical Trial: Ju Hyun Shim Listed a New Clinical Trial to Study Regorafenib After Treatment Failure of First Line Immune Checkpoint Inhibitor Treatment in Advanced Hepatocellular Carcinoma Patients (RECOMEND)
    Media name/outletContify Life Science News
    Country/TerritoryIndia
    Date26.04.7
    PersonsHyunJoo Shim
View all 1
View less